National Institutes of Health (NIH) Chooses Blue Heron Biotechnology In Emergency Response to Swine Flu Threat
BOTHELL, Wash.--(BUSINESS WIRE)--BLUE HERON BIOTECHNOLOGY announced today that it delivered a critical synthetic DNA gene sequence in just three days in response to the National Institutes of Health request for assistance in combating the outbreak of Swine Flu. “We are gratified that the NIH has placed their confidence and trust in Blue Heron in this time of crisis. We were able to draw on our ten years of gene synthesis expertise to come up with an approach to deliver this critical research tool to the NIH in far less time than usual” said John Mulligan, Blue Heron’s Chief Scientific Officer. The synthesized gene was part of the H1N1 virus and was delivered using Blue Heron’s proprietary GeneMaker gene synthesis platform.